3 Results for "

NREM

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "NREM" in MCE Product Catalog:

Cat. No.: HY-111178
CAS No.: 90280-13-0
Purity:  99.18%
Synonyms: BisfluoroModafinil; CRL-40940; NLS-4
Target:  

Dopamine Transporter

Research Areas:  

Neurological Disease

Lauflumide (BisfluoroModafinil) is a selective dopamine reuptake inhibitor and wake-promoting agent. Lauflumide inhibits the dopamine transporter (DAT). Lauflumide induces sustained wakefulness without eliciting hyperlocomotion, stereotypy or abnormal behaviors in Mus musculus (house mice). Lauflumide reduces non-rapid eye movement (NREM) sleep rebound in rats, modulates electroencephalogram (EEG) spectral composition, and produces anti-aggressive effects. Lauflumide alleviates circadian rhythm disturbances in rats, increases spontaneous activity in fatigued rats, and facilitates their recovery from severe fatigue. Lauflumide can be used in research related to excessive daytime sleepiness as well as chronic severe fatigue/chronic fatigue syndrome (CFS) .
loading...
    loading...
Cat. No.: HY-115304
CAS No.: 101374-18-9
Target:  

Melatonin Receptor

Research Areas:  

Neurological Disease

UCM 793 is a non-selective MT1/MT2 receptor agonist (pKis: 9.09 (MT1 receptor); 9.19 (MT2 receptor)). UCM793 increases the number of episodes and decreases the length of the episodes of wakefulness. UCM 793 influences quality of the vigilance states. UCM 793 decreases sleep onset without having an effect on NREM sleep maintenance .
loading...
    loading...
Cat. No.: HY-184478
CAS No.: 3103822-75-6
Target:  

GABA Receptor

Research Areas:  

Neurological Disease

GABAA receptor modulator-14 is an orally active, blood-brain barrier permeable selective positive allosteric modulator (PAM) of extrasynaptic δ-containing GABAA receptors (α4β3δ subtype) with an EC50 of 0.8 μM. GABAA receptor modulator-14 selectively enhances tonic neuronal inhibition by potentiating GABA-evoked currents mediated by extrasynaptic δ-GABAARs, produces rapid sustained antidepressant effects, elevates slow-wave NREM sleep and shows no addiction liability in mice. GABAA receptor modulator-14 can be applied to major depressive disorder (MDD) and comorbid insomnia research .
loading...
    loading...